πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Delcath Systems, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Castle Biosciences, Inc.

Castle Biosciences, Inc. logo
Market Cap: Medium
Employees: Medium

Decision Dx-Melanoma

Castle Biosciences, Inc. is a commercial-stage diagnostics company providing diagnostic and prognostic testing services for dermatological cancers, including products like Decision Dx-Melanoma for invasive cutaneous melanoma and other proprietary GEP tests.

Tags: dermatological cancers, diagnostics, metastasis risk, multi-gene expression profile, squamous cell carcinoma, uveal melanoma

Symbol: CSTL

Recent Price: $26.66

Industry: Medical - Diagnostics & Research

CEO: Mr. Derek J. Maetzold

Sector: Healthcare

Employees: 710

Address: 505 South Friendswood Drive, Friendswood, TX 77546

Phone: 866 788 9007

Leadership

  • Derek Maetzold, Founder, President, CEO and Director
  • Frank Stokes, Chief Financial Officer
  • Kristen Oelschlager, CHIEF OPERATING OFFICER
  • Toby Juvenal, CHIEF COMMERCIAL OFFICER
  • Sherri Borman, Ph.D., Executive Laboratory Director
  • John Abbott, VICE PRESIDENT, FINANCE
  • Rebecca Critchley-Thorne, Ph.D., vice president, research & development
  • Jay Braxton, Pharm.D., Vice President, Marketing and brand manager, uveal melanoma (um)
  • Hillary Caruso, Ph.D., Vice President, Strategic Operations
  • John Cheneval, Executive Director, Business Development
  • Kevin Doman, Vice President, Sales
  • Vicki Fish, Vice President, Skin Cancer Marketing
  • Matthew Goldberg, M.D., Senior vice president, medical
  • Keli Greenberg, Vice President, Human Resources
  • Alice Izzo, Vice President, regulatory and government affairs
  • Clare Johnson, R.N., Vice President, Clinical Research
  • Michael Maltby, Executive Director, Managed Care
  • Noreen Manning, Vice President, Reimbursement
  • Chris Otte, Vice President, Information Technology
  • Trisha Poteet, Vice President, Clinical Services
  • Camilla Zuckero, Vice President, Investor Relations & Corporate Affairs
  • Daniel Bradbury, Board Chairman
  • Kimberlee Caple, Director
  • G. Bradley Cole, Director
  • Rodney Cotton, Director
  • Ellen Goldberg, Director
  • Miles Harrison, Director
  • Tiffany Olson, Director

Last updated: 2024-12-31

Dynavax Technologies Corporation

Dynavax Technologies Corporation logo
Market Cap: High
Employees: Medium

HEPLISAV-B

Dynavax Technologies Corporation is a biopharmaceutical company focusing on the development and commercialization of novel vaccines, including HEPLISAV-B, a hepatitis B vaccine. It collaborates with several international partners and is headquartered in Emeryville, California.

Tags: HEPLISAV-B, biopharmaceutical, biotech, hepatitis B, pharmaceutical partnerships, vaccines

Symbol: DVAX

Recent Price: $12.83

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Ryan Spencer

Sector: Healthcare

Employees: 408

Address: 2100 Powell Street, EmeryVille, CA 94608

Phone: 510 848 5100

Last updated: 2024-12-31

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Rencofilstat

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing drug therapies for chronic liver diseases, particularly through the development of Rencofilstat, a cyclophilin inhibitor aimed at treating non-alcoholic steatohepatitis (NASH) and reducing liver fibrosis and tumors.

Tags: NASH, Rencofilstat, biopharmaceutical, cyclophilin inhibitor, drug therapy, liver disease

Symbol: HEPA

Recent Price: $0.43

Industry: Biotechnology

CEO: Mr. John Patrick Brancaccio CPA

Sector: Healthcare

Employees: 22

Address: 399 Thornall Street, Edison, NJ 08837

Phone: 732 902 4000

Leadership

  • John P. Brancaccio, Interim Chief Executive Officer, Interim Chief Financial Officer, and Chairman of the Board

Last updated: 2024-12-31

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. logo
Market Cap: Highest
Employees: Medium

ENHANZE drug delivery technology

Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.

Tags: ENHANZE, biologics, biopharma, drug delivery, technology, therapeutics

Symbol: HALO

Recent Price: $47.99

Industry: Biotechnology

CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.

Sector: Healthcare

Employees: 373

Address: 11388 Sorrento Valley Road, San Diego, CA 92121

Phone: 858 794 8889

Last updated: 2024-12-31

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

zilovertamab, ONCT-216, ONCT-808, ONCT-534

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.

Tags: CAR-T, ROR1, antibody, biopharmaceutical, cancer therapy, clinical-stage, oncology

Symbol: ONCT

Recent Price: $0.53

Industry: Biotechnology

CEO: Dr. James B. Breitmeyer M.D., Ph.D.

Sector: Healthcare

Employees: 27

Address: 12230 El Camino Real, San Diego, CA 92130

Phone: 858 434 1113

Last updated: 2024-12-31

Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

SNDX-5613, SNDX-6352 (axatilimab), Entinostat

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.

Tags: Collaborations, Entinostat, Monoclonal Antibody, SNDX-5613, SNDX-6352, biopharmaceutical, cancer therapy, clinical-stage

Symbol: SNDX

Recent Price: $12.52

Industry: Biotechnology

CEO: Mr. Michael A. Metzger M.B.A.

Sector: Healthcare

Employees: 184

Address: 35 Gatehouse Drive, Waltham, MA 02451

Phone: 781 419 1400

Last updated: 2024-12-31

DaVita Inc.

DaVita Inc. logo
Market Cap: Highest
Employees: Highest

Kidney Dialysis Services

Da Vita Inc. provides comprehensive kidney dialysis services through outpatient centers, serving patients with chronic kidney failure. They offer a variety of services including home-based hemodialysis, laboratory tests, disease management, and integrated care arrangements.

Tags: Clinical Services, Healthcare, Integrated Care, Kidney Dialysis, Outpatient Care

Symbol: DVA

Recent Price: $149.79

Industry: Medical - Care Facilities

CEO: Mr. Javier J. Rodriguez

Sector: Healthcare

Employees: 70000

Address: 2000 16th Street, Denver, CO 80202

Phone: 720 631 2100

Last updated: 2024-12-31

Baxter International Inc.

Baxter International Inc. logo
Market Cap: Highest
Employees: Highest

Healthcare Products

Baxter International Inc. develops and provides a wide range of healthcare products worldwide, including dialysis therapies, intravenous and infusion therapies, medical devices for surgery, and patient monitoring technologies.

Tags: Dialysis, Healthcare, Medical Devices, Patient Monitoring, Pharmaceuticals

Symbol: BAX

Recent Price: $28.63

Industry: Medical - Instruments & Supplies

CEO: Mr. Jose E. Almeida

Sector: Healthcare

Employees: 60000

Address: One Baxter Parkway, Deerfield, IL 60015

Phone: 224 948 2000

Last updated: 2024-12-31

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. logo
Market Cap: Low
Employees: Low

HETLIOZ, Fanapt

Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for high unmet medical needs, including marketed products like HETLIOZ for sleep-wake disorders and Fanapt for schizophrenia, with ongoing development for other conditions.

Tags: Fanapt, HETLIOZ, biopharmaceutical, schizophrenia, sleep disorders, therapies

Symbol: VNDA

Recent Price: $4.78

Industry: Biotechnology

CEO: Dr. Mihael H. Polymeropoulos M.D.

Sector: Healthcare

Employees: 203

Address: 2200 Pennsylvania Avenue NW, Washington, DC 20037

Phone: 202 734 3400

Last updated: 2024-12-31

Blueprint Medicines Corporation

Blueprint Medicines Corporation logo
Market Cap: Highest
Employees: Medium

AYVAKIT, BLU-263, Fisogatinib, GAVRETO, BLU-701, BLU-945, BLU-451, BLU-782

Blueprint Medicines Corporation is a precision therapy company focused on developing medicines for genomically defined cancers and blood disorders, including treatment for systemic mastocytosis, gastrointestinal stromal tumors, hepatocellular carcinoma, and non-small-cell lung carcinoma.

Tags: AYVAKIT, BLU-263, Fisogatinib, GAVRETO, blood disorders, epidermal growth factor receptor, genomically defined cancers, non-small cell lung cancer, precision therapy, solid tumors

Symbol: BPMC

Recent Price: $86.82

Industry: Biotechnology

CEO: Ms. Kathryn Haviland M.B.A.

Sector: Healthcare

Employees: 638

Address: 45 Sidney Street, Cambridge, MA 02139

Phone: 617 374 7580

Last updated: 2024-12-31

Delcath Systems, Inc.

Delcath Systems, Inc. logo
Market Cap: Low
Employees: Low

HEPZATO KIT

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers in the United States and Europe, with its lead product candidate being the HEPZATO KIT.

Tags: HEPZATO KIT, Interventional Oncology, Liver Cancer, Melphalan, Metastatic Uveal Melanoma

Symbol: DCTH

Recent Price: $11.89

Industry: Medical - Specialties

CEO: Mr. Gerard J. Michel MBA, MS

Sector: Healthcare

Employees: 76

Address: 1633 Broadway, New York, NY 10019

Phone: 212 489 2100

Last updated: 2024-12-31

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

4D-125, 4D-110, 4D-310, 4D-150, 4D-710

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.

Tags: biotechnology, cardiology, gene therapy, ophthalmology, pulmonology

Symbol: FDMT

Recent Price: $5.30

Industry: Biotechnology

CEO: Dr. David H. Kirn M.D.

Sector: Healthcare

Employees: 201

Address: 5858 Horton Street, EmeryVille, CA 94608

Phone: 510 505 2680

Last updated: 2024-12-31

Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Decoy20

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.

Tags: Decoy20, anti-cancer, anti-viral, biotechnology, immunotherapy

Symbol: INDP

Recent Price: $0.87

Industry: Biotechnology

CEO: Mr. Jeffrey A. Meckler

Sector: Healthcare

Employees: 7

Address: 3 Columbus Circle, New York, NY 10019

Phone: 347 480 9760

Last updated: 2024-12-31

MEI Pharma, Inc.

MEI Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

Zandelisib

MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.

Tags: Voruciclib, Zandelisib, cancer therapy, clinical trials, oncology, pharmaceutical

Symbol: MEIP

Recent Price: $2.45

Industry: Biotechnology

CEO: Mr. Justin J. File

Sector: Healthcare

Employees: 28

Address: 11455 El Camino Real, San Diego, CA 92130

Phone: 858 369 7100

Last updated: 2024-12-31

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. logo
Market Cap: Lowest
Employees: Lowest

INTASYL therapeutic platform

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.

Tags: ACT, BRD4, Biotechnology, Cancer, Immuno-Oncology, PD-1, TIGIT, Therapeutics

Symbol: PHIO

Recent Price: $1.90

Industry: Biotechnology

CEO: Mr. Robert J. Bitterman

Sector: Healthcare

Employees: 8

Address: 257 Simarano Drive, Marlborough, MA 01752

Phone: 508 767 3861

Last updated: 2024-12-31

Scopus BioPharma Inc.

Scopus BioPharma Inc. logo
Market Cap: Lowest
Employees: Lowest

Duet Platform

Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.

Tags: biopharmaceutical, cancer treatment, gene therapy, immuno-oncology, therapeutics

Symbol: SCPS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Alan D. Horsager Ph.D.

Sector: Healthcare

Employees: 13

Address: 420 Lexington Avenue, New York, NY 10170

Phone: 212 479 2513

Last updated: 2024-12-31

Galecto, Inc.

Galecto, Inc. logo
Market Cap: Lowest
Employees: Lowest

GB2064

Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.

Tags: biotechnology, cancer, clinical trials, fibrosis, inflammation, pharmaceutical

Symbol: GLTO

Recent Price: $4.60

Industry: Biotechnology

CEO: Dr. Hans T. Schambye M.D., Ph.D.

Sector: Healthcare

Employees: 13

Address: 75 State Street, Boston, MA 02109

Phone: 457 070 5210

Last updated: 2024-12-31

Intuitive Surgical, Inc.

Intuitive Surgical, Inc. logo
Market Cap: Highest
Employees: Highest

da Vinci Surgical System, Ion endoluminal system

Intuitive Surgical, Inc. develops, manufactures, and markets products that enhance minimally invasive care. It offers the da Vinci Surgical System and Ion endoluminal system for complex surgeries and diagnostic procedures, along with a range of instruments and services to support healthcare providers.

Tags: Healthcare, Innovation, Medical Devices, Minimally Invasive Care, Surgical Systems

Symbol: ISRG

Recent Price: $526.96

Industry: Medical - Instruments & Supplies

CEO: Dr. Gary S. Guthart Ph.D.

Sector: Healthcare

Employees: 13676

Address: 1020 Kifer Road, Sunnyvale, CA 94086-5304

Phone: 408 523 2100

Last updated: 2024-12-31

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. logo
Market Cap: Highest
Employees: Medium

DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.

Tags: cardiovascular, diagnostic products, healthcare, oncology, radiotherapy, therapeutic products

Symbol: LNTH

Recent Price: $89.13

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Brian A. Markison

Sector: Healthcare

Employees: 834

Address: 331 Treble Cove Road, North Billerica, MA 01862

Phone: 978 671 8001

Leadership

  • Brian Markison, Chief Executive Officer
  • Paul Blanchfield, President
  • Jeff Humphrey, MD, Chief Medical Officer
  • Robert J. Marshall Jr., Chief Financial Officer
  • Amanda Morgan, Chief Commercial Officer
  • Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
  • Jean-Claude Provost, MD, Chief Science Officer
  • Jamie Spaeth, Chief People Officer
  • Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
  • Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
  • Kim Brown, Chief Accounting Officer
  • Lee Anne Howe, Chief Information Officer
  • Linda Lennox, Chief of Staff & Vice President, Corporate Communications
  • Joann Nestor, Senior Vice President, Legal Affairs
  • Andrea Sabens, Vice President, Business Optimization
  • Carol Walker, Senior Vice President, Quality
  • Mary Anne Heino, Chairperson of the Board
  • Minnie Baylor-Henry, Director
  • GΓ©rard Ber, PhD, Director
  • Julie Eastland, Director
  • Samuel Leno, Director
  • Heinz MΓ€usli, Director
  • Julie McHugh, Director
  • Gary J. Pruden, Director
  • James H. Thrall, MD, Director

Last updated: 2024-12-31

The Oncology Institute, Inc.

The Oncology Institute, Inc. logo
Market Cap: Lowest
Employees: Medium

Medical Oncology Services

An oncology company providing medical oncology services in the United States, including clinical trials, radiation, outpatient stem cell transplants, and patient support, serving adult and senior cancer patients with 67 clinic locations.

Tags: Cancer Care, Clinical Trials, Medical Services, Oncology, Patient Support, Stem Cell Transplants

Symbol: TOI

Recent Price: $0.32

Industry: Medical - Care Facilities

CEO: Dr. Daniel Virnich FACHE, M.B.A., M.D.

Sector: Healthcare

Employees: 800

Address: 18000 Studebaker Road, Cerritos, CA 90703

Phone: 213 760 1328

Last updated: 2024-12-31